An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 10 Jul 2017
At a glance
- Drugs Epetraborole (Primary)
- Indications Community-acquired pneumonia; Gram-negative infections
- Focus Pharmacokinetics
- 26 Jul 2011 Actual end date Mar 2011 added as reported by ClinicalTrials.gov.
- 26 Jul 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jan 2011 New trial record